Si desitges distingir els teus productes, serveis o tots dos dels d'una altra empresa, és possible que necessitis una marca o nom comercial. Descobreix què són, en què consisteix el seu procediment de registri i què implica.
Información sobre los plazos de presentación de solicitudes de transformación de marcas de la Unión Europea en marca nacional española. Más información
Si tens un nou dispositiu, producte o procediment que resolgui un problema tècnic o tingui un avantatge pràctic, existeixen diferents formis de protegir-ho a Espanya i en altres països. Descobreix com fer-ho.
La teva innovació resideix en l'estètica, l'ornamentació o l'aparença del teu producte? Protegeix-la mitjançant un disseny industrial. Descobreix quins drets confereix el registri i com realitzar la tramitació.
Les indicacions geogràfiques protegeixen el nom d’un producte originari d’una zona geogràfica, a la qual li deu una determinada qualitat, reputació o una altra característica. Descobreix què són, en què consisteix el seu procediment de registre i quins beneficis atorguen.
Els patents publicades a tot el món són una valuosa font d'informació científica, tècnica i comercial.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
Si ets emprenedor/a o una empresa i vols potenciar i millorar la rendibilitat del teu negoci protegint de forma adequada els actius intangibles de la teva organització, en aquest espai trobaràs el necessari.
150
resultados
Última actualización
30/11/2025 [06:54:00]
Resultados 100 a 125 de 150
Resumen de: WO2025212748A1
Methods and associated devices for establishing basal rates to be programmed into a diabetic pump that periodically administers insulin to a patient. The instant disclosure also includes diabetic pumps programmed in accordance with the instant disclosure.
Resumen de: WO2025212345A1
A variability metric of glucose level values of a user is calculated for each candidate sleeping time frame in a data set of glucose level values of the user obtained over time for a specified period for each day of multiple days. Each of the candidate sleeping time frames may represent a duration in which the user may have been sleeping. Execution of the programming instructions further may cause the processor to determine a mean or median of the variability metric of the glucose level values in the data set for each candidate sleeping time frame across the days in the specified period, designate a selected one of the candidate sleeping time frames that has the lowest mean or median variability metric as the sleeping time frame, and configure the pump to deliver a sleeping basal rate of the medicament for the designated sleeping time frame.
Resumen de: US2025316358A1
Methods and associated devices for establishing basal rates to be programmed into a diabetic pump that periodically administers insulin to a patient. The instant disclosure also includes diabetic pumps programmed in accordance with the instant disclosure.
Resumen de: AU2025234254A1
SAFETY TOOLS FOR DECISION SUPPORT RECOMMENDATIONS MADE TO USERS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS Systems and method are described for determining if a decision support recommendation is to be presented to a user for treatment of a diabetic state, including receiving a plurality of input data items impacting a diabetic state of a user of continuous glucose monitor, the input data items serving as input data to a process for determining a decision support recommendation; assigning a reliability level to each of the input data items; calculating a reliability metric based on the reliability levels assigned to each of the input data items; determining a decision support recommendation based on the process and the input data and presenting the decision support recommendation to the user on a user interface only if the reliability metric exceeds a threshold. SAFETY TOOLS FOR DECISION SUPPORT RECOMMENDATIONS MADE TO USERS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS Systems and method are described for determining if a decision support recommendation is to be presented to a user for treatment of a diabetic state, including receiving a plurality of input data items impacting a diabetic state of a user of continuous glucose monitor, the input data items serving as input data to a process for determining a decision support recommendation; assigning a reliability level to each of the input data items; calculating a reliability metric based on the reliability levels assigned to each
Resumen de: US2025315997A1
Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.
Resumen de: WO2025211979A1
The invention relates to medicine, and more particularly to devices for non-invasively determining a person's blood glucose concentration, and can be used in the creation of systems for diagnosing diabetes. The present device comprises a housing, and a control and display module disposed in the housing. The device further comprises a sensor, a radiation emitter, and a receiver for receiving radiation reflected from a person's tissues, the emitter and the receiver being disposed in the sensor. Disposed on the working surface of the sensor is a rim which surrounds the light receiver and separates it from the light emitter. The device is incorporated into a smartphone, with a control and data processing unit being disposed in the housing of the smartphone and the device being powered by the power supply of the smartphone. The function of a data display panel is performed by the touchscreen of the smartphone, and the sensor is disposed on the rear surface of the smartphone housing, near the upper edge thereof. The invention provides a simplified design, the possibility of visually checking the correct positioning of the sensor on a pulse point, and the possibility of keeping the device in a working state using one hand while simultaneously operating the touchscreen using a digit of the same hand.
Resumen de: WO2025211546A1
This method for operating a device for providing a glucose management service comprises the steps of: acquiring discontinuous glucose data for a user which is discontinuously measured; detecting an abnormal change in glucose of the user on the basis of user data including the discontinuous glucose data; calculating a score on the necessity for continuous glucose measurement on the basis of determination information including the detection result of the abnormal change; and recommending continuous glucose measurement to the user on the basis of the necessity score of the continuous glucose measurement.
Resumen de: WO2025211978A1
The invention relates to medicine and technology, and more particularly to non-invasively detecting a change in a person's blood glucose concentration, and can be used in the creation of sensors for non-invasively checking a person's blood glucose concentration. The aim of the invention is to improve the operational efficiency of a sensor of a device for non-invasively checking a person's blood glucose concentration by reducing the set-up and configuration time required. This aim is achieved in that the claimed sensor of a device for non-invasively checking a person's blood glucose concentration comprises a housing, a light emitter and a light receiver, the inner side of the housing having a rim disposed thereon which surrounds the light receiver and separates it from the light emitter, wherein the crest of said rim has alternating projections and depressions along its length, and during the set-up and operation of the sensor, the emitter and the receiver are pressed against the pulse point on the radial artery of the arm. The technical results of the invention include: increasing the adhesive force between the rim and a person's arm by increasing the contact area between said rim and the surface of the arm; reducing the energy spent on non-invasively checking a person's blood glucose concentration; and increasing heat transfer from the sensor via the crest of the rim to the person's arm by increasing the contact area between the rim and the arm.
Resumen de: US2025316375A1
Glucose prediction using machine learning (ML) and time series glucose measurements is described. Given the number of people that wear glucose monitoring devices and because some wearable glucose monitoring devices can produce measurements continuously, a platform providing such devices may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process and covers a robust number of state spaces unlikely to be covered without the enormous amount of data. In implementations, a glucose monitoring platform includes an ML model trained using historical time series glucose measurements of a user population. The ML model predicts upcoming glucose measurements for a particular user by receiving a time series of glucose measurements up to a time and determining the upcoming glucose measurements of the particular user for an interval subsequent to the time based on patterns learned from the historical time series glucose measurements.
Resumen de: WO2025209494A1
The present application provides a blood glucose monitoring method. The method comprises: determining a first early warning duration according to first blood glucose data, wherein the first blood glucose data comprises blood glucose data within a first time period, and the first early warning duration is used for performing hypoglycemia early warning. The first early warning duration is related to blood glucose fluctuation indicated by the first blood glucose data. If the blood glucose indicated by the first blood glucose data fluctuates little and changes slowly, the first early warning duration can be longer. If the first blood glucose data input into a model indicates that the blood glucose of a user fluctuates greatly and changes rapidly in historical time, the first early warning duration can be shorter. By means of implementing the described method, the electronic device can adaptively adjust the first early warning duration according to the characteristics of the blood glucose variability of a user, thereby improving the accuracy of hypoglycemia early warning.
Resumen de: US2025312239A1
Extractors and methods of extracting a medication from another medical device, such as an insulin pen. The extractor includes a syringe, a first cap having an open end adapted to be coupled to the syringe, a hypodermic needle protruding from a closed end of the first cap, and a second cap coupled at a closed end thereof to the first cap by the hypodermic needle, which extends through the closed end of the second cap and protrudes into an internal cavity of the second cap such that an internal cavity of the first cap fluidically communicates with the internal cavity of the second cap through the hypodermic needle. An open end of the second cap can be coupled to the medical device so that the internal cavity of the second cap fluidically communicates with the medical device through the hypodermic needle.
Resumen de: US2025311950A1
The present disclosure relates to a microneedle analyte sensing device for continuous monitoring of an analyte in a user's biological fluid, specifically designed for detecting ketone levels in diabetic ketoacidosis (DKA) management. The disclosed microneedle analyte sensing device utilizes dopamine (DA) molecules covalently linked to the microneedle patch's polymer structure or toluidine blue O (TBO), serving as a redox mediator for measuring the oxidation byproduct of 3-beta-hydroxybutyrate (β-HB). The sensing mechanism relies on catechol-quinone chemistry, where a pre-oxidation approach correlates sensor response to β-HB concentrations. The device comprises a plurality of microneedles on a substrate that, when applied to the skin, penetrate the stratum corneum to contact biological fluid. At least one microneedle functions as a working electrode to detect an electrochemical signal from the enzymatic reaction with the analyte, while additional microneedles serve as counter and reference electrodes to facilitate accurate electrochemical measurements.
Resumen de: US2025311946A1
An analyte monitoring device is disclosed. The analyte monitoring device comprises an analyte sensor configured to be at least partially inserted into a body of a user to detect a signal related to glucose concentration, and a sensor electronics unit electrically connected to the analyte sensor to acquire the signal, wherein the sensor electronics unit is configured to: perform communication connection with a user terminal, transmit information about the sensor electronics unit to the user terminal, receive, from the user terminal, a second security key generated based on the information about the sensor electronics unit and a first security key, perform verification of the second security key, and determine whether to maintain the communication connection based on the verification result.
Resumen de: EP4628012A1
Provided is a sensor applicator assembly for a blood glucose monitoring including a body-attachable unit including an upper frame and a lower frame that is disposed under the upper frame and has a surface attached to a body and an applicator within which the body-attachable unit is disposed. The upper frame includes a first area and a second area disposed under the first area and in contact with the lower frame. A perimeter of an outer peripheral surface of the second area is identical to a perimeter of an outer peripheral surface of the lower frame.
Resumen de: AU2023401746A1
Techniques for performing application-layer security and communication over primary invitation channels arc disclosed. In certain embodiments, analyte data is obtained from an analyte sensor electrically coupled to a sensor electronics module of an analyte sensor system. A secret key is established with a display device over one or more primary invitation channels. The analyte data is encrypted using the secret key. The encrypted analyte data is broadcast over the one or more primary invitation channels.
Resumen de: EP4629684A1
An analyte monitoring device is disclosed. The analyte monitoring device comprises an analyte sensor configured to be at least partially inserted into a body of a user to detect a signal related to glucose concentration, and a sensor electronics unit electrically connected to the analyte sensor to acquire the signal, wherein the sensor electronics unit is configured to: perform communication connection with a user terminal, transmit information about the sensor electronics unit to the user terminal, receive, from the user terminal, a second security key generated based on the information about the sensor electronics unit and a first security key, perform verification of the second security key, and determine whether to maintain the communication connection based on the verification result.
Resumen de: WO2024118976A1
Embodiments disclosed herein are directed to ambulatory infusion pump systems that integrate a CGM sensor and/or a pressure sensor with an ambulatory infusion pump via a pump holder or tray that releasably holds the pump and is configured to be worn by a user, wherein the ambulatory infusion pump includes an inductive charging coil and the tray includes an inductive coil configured to be aligned with the inductive charging coil to receive power from the inductive charging coil, and wherein a processor is configured to receive and process glucose signals from the CGM sensor and pressure signals from the pressure sensor through the inductive charging coil.
Resumen de: CN223404176U
The utility model belongs to the technical field of medical instruments, and particularly relates to a urinary catheterization suite for the urology department. The end part of the catheterization input port is fixedly connected with a urine collecting pipe; the end part of the urine collecting pipe is fixedly connected with a first conveying pipe; a liquid guide pipe is arranged at the end part of the first conveying pipe; a temperature measuring assembly is arranged on the side wall of the liquid guide pipe; a urine sugar measuring assembly is arranged on the other side wall of the liquid guide pipe; a storage assembly is arranged on the other side wall of the liquid guide pipe; a second conveying pipe is mounted at the end part of the liquid guide pipe; through the arrangement of a rotating plate, contraction of a clamping rubber plate can be controlled through a sliding hole and a control rod, the size of an inner ring of a catheterization input opening is adjusted according to different patients, the urine leakage condition is reduced, through the arrangement of a temperature measuring assembly, a urine sugar measuring assembly and a storage assembly, the temperature and sugar of urine can be detected, and the detection accuracy is improved. And excessive urine is collected, so that the urine leakage condition of the urinary catheterization suite for the urology department is reduced.
Resumen de: CN120733171A
The artificial pancreas control system comprises an artificial pancreas and at least one function control device, the artificial pancreas comprises an insulin infusion device and a blood glucose monitoring device, and the function control device comprises a communication module and an instruction interaction module. The function control device is in communication connection with the insulin infusion device or the blood glucose monitoring device through the communication module, before meal, a user implements a meal operation instruction through the instruction interaction module, and the insulin infusion device and the blood glucose monitoring device execute a meal control instruction corresponding to the meal operation instruction so as to cope with blood glucose rise caused by food; compared with intelligent equipment, the function control equipment is simple in structure, convenient to operate and carry and convenient for users to use.
Resumen de: CN120733187A
The injection pump comprises an insulin pump body and further comprises a medicine storage device, a medicine changing assembly, an exhaust device and a medicine pushing assembly, the medicine storage device is detachably connected with the insulin pump body, a plurality of medicine bags are placed in the medicine storage device, the medicine changing assembly is arranged in the medicine storage device, the medicine changing assembly is pressed, and the medicine pushing assembly is arranged in the medicine storage device. The medicine changing assembly automatically changes the medicine bag, the exhaust device is arranged in the insulin pump body and automatically exhausts air after the medicine bag is replaced, the medicine pushing assembly is arranged in the insulin pump body and pushes the medicine bag, and insulin injection in the medicine bag is completed. The device has the advantages that the medicine storage device is used for storing multiple tubes of insulin, the storage amount of the insulin is increased, the medicine changing assembly is used for achieving automatic medicine changing, the medicine changing process is simplified, the medicine changing time is shortened, the exhaust device is used for achieving automatic exhaust of the insulin after changing, the situation that an indwelling needle needs to be pulled out in the insulin changing process is avoided, and repeated needle inserting is avoided; and the comfort of the patient is improved.
Resumen de: CN120732382A
The invention belongs to the technical field of diabetic foot detection, and provides a diabetic foot monitoring system. Comprising a multi-sensor collaborative data acquisition module, a data preprocessing and feature extraction module, a data encapsulation and transmission module, a time sequence data modeling module, a time sequence data training module, a model lightweight deployment and real-time prediction module, a multi-stage early warning trigger module, a personalized health suggestion generation module and a real-time monitoring module. A local fault diagnosis and abnormity determination module; and a user side interaction and maintenance execution module. By adopting the sensor array, the foot risk is comprehensively reflected, and the wearing experience of a user is improved; low-delay early warning is realized through a local deployment prediction model; by arranging the personalized health suggestion generation module, the threshold value is dynamically adjusted according to the medical history and living habits of the patient, and the personalization of the system is improved.
Resumen de: CN120732407A
The invention relates to the technical field of sensing detection, in particular to a wearable sensing type multi-component sweat sensing patch, a preparation method of the wearable sensing type multi-component sweat sensing patch and an intelligent detection system.The wearable sensing type multi-component sweat sensing patch comprises an epidermal contact layer, a thermal stimulation layer, a micro-fluidic channel, a sensing layer and a breathable packaging layer; the sensing layer is arranged at one end of the micro-fluidic channel and comprises four independent cavities which are used for loading different signal probes respectively and carrying out chromogenic reaction with a target object in sweat. According to the invention, sweat is driven to be directionally transmitted through capillary action, and synchronous detection of four targets in the sweat is realized; different signal probes are selectively combined with calcium ions, potassium ions, uric acid and glucose, molecular combination is converted into color signals through nanoparticle aggregation or indicator replacement, meanwhile, sweat generation and collection are optimized through the thermal stimulation layer, calibration and signal stability of the sweat sensing patch is improved, the sweat sensing patch is made to meet the real-time monitoring requirement, and the sweat sensing patch is suitable for real-time monitoring. And the sensitivity is relatively high.
Resumen de: CN120732406A
The invention relates to the technical field of medical equipment, and discloses a rapid detection device for treatment of diabetic patients, the rapid detection device comprises a rack, one side of the top of the rack is slidably connected with two moving plates, the outer side of one moving plate is fixedly connected with a connecting plate, the end of the connecting plate is fixedly connected with a rigid traction rope, and the rigid traction rope is fixedly connected with the other side of the rack. A mounting frame is fixedly connected to the inner side of the rack, two fixing rods are fixedly connected to the interior of the mounting frame, a movable plate is slidably connected to the exteriors of the fixing rods, and two hinge rods are hinged to the top of the movable plate. By innovatively designing a blood glucose detection tray structure capable of being automatically stored, the equipment is effectively protected in a non-use state, and the durability and reliability of the equipment are remarkably improved. After detection is completed, the equipment can automatically store the blood glucose detection tray into the rack, and the risk that the arm tray is damaged due to accidental collision or external force when the arm tray is idle is avoided through the design.
Resumen de: CN120748615A
The invention discloses a kidney protection method and system for accurate insulin administration, and relates to the technical field of medical control methods, and the method comprises the steps: obtaining body position data and urination data of a target patient, and carrying out the time alignment; performing time compensation on urination intermittence according to the body position data to obtain urination data without body position influence; comparing the compensated urination data with preset standard urination rhythm data, and judging whether the urination rhythm of the patient is abnormal or not; if so, calculating an insulin clearing compensation coefficient; respectively adjusting the insulin infusion rate, the injection time interval or the injection dosage according to different threshold intervals of the coefficient; and finally, generating and sending an insulin administration instruction. The pharmaceutical composition has the beneficial effects that the insulin accumulation risk can be reduced, the hypoglycemia occurrence probability is reduced, meanwhile, the renal function is protected, kidney injury caused by drugs is avoided, stable blood glucose control and kidney protection are better considered, and the pharmaceutical composition is particularly suitable for personalized treatment requirements of elderly diabetics.
Nº publicación: CN223404199U 03/10/2025
Solicitante:
LI JUAN
\u674E\u5A1F
Resumen de: CN223404199U
The utility model relates to the technical field of medical treatment, in particular to an insulin pump for a diabetic patient, which comprises a box body, a pump body and an insulin pump, the protection mechanism comprises a protection cover and a connecting plate, the protection cover is arranged on the surface of the pump body, and the connecting plate is arranged on the surface of the pump body; and the carrying mechanism comprises a mounting plate, and the mounting plate is arranged on the surface of the pump body. Through the fixed connection of the protective cover and the connecting rotating shaft, the through connection of the protective cover and the connecting rod, the fixed connection of the connecting rod and the knob, the fixed connection of the connecting rod and the connecting cylinder, the fixed connection of the connecting cylinder and the reset spring, and the fixed connection of the reset spring and the limiting block, after the insulin pump is debugged, the insulin pump is debugged; when the pump body is used, the pump body can be covered by the protective cover, and the protective cover and the connecting plate are locked by rotating the knob, so that the pump body is protected, and a patient cannot mistakenly touch keys on the pump body to cause negative effects.
BOPI
Sede Electrónica
